Seoul, South Korea

Hunil Lim

This inventor holds 2 USPTO granted patents and 33 published patent applications and 1 EPO patent. Top assignee: Kt&g Corporation. Active years: 2026.

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Mind of Hunil Lim

Introduction

Hunil Lim is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of technology, particularly in the area of electronic device security. His innovative approach to user verification has led to the development of a unique patent that enhances the user experience.

Latest Patents

Hunil Lim holds a patent for a "Method and apparatus for unlocking based on user input." This invention involves a method for unlocking electronic devices by displaying a verification screen for registered users. The system determines whether the user is registered based on their input and unlocks the device accordingly. This patent showcases Lim's commitment to improving security and usability in electronic devices. He has 1 patent to his name.

Career Highlights

Hunil Lim is currently employed at KT&G Corporation, a leading company in the tobacco and ginseng industries. His role at the company allows him to work on innovative projects that push the boundaries of technology. Lim's expertise and dedication have made him a valuable asset to his team.

Collaborations

Hunil Lim collaborates with talented individuals such as Yong Hwan Kim and Dong Sung Kim. Their combined efforts contribute to the advancement of technology and innovation within their projects.

Conclusion

Hunil Lim is an inspiring inventor whose work in electronic device security exemplifies the importance of innovation in technology. His contributions continue to shape the future of user verification methods.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…